Last checked at 6 Sep 2013 16:16
ECO Animal Health Group plc
(“Eco” or the “Company”)
06 September 2013
The Company has been informed that an employee has exercised options to purchase 11,500 new shares of 5p each in the Company at an exercise price of £0.85 per share.
Application has been made for the 11,500 new Ordinary Shares to be admitted to trading on the Alternative Investment Market (“AIM”)of London Stock Exchange plc. Admission of the new Ordinary Shares is expected to become effective on 12 September 2013.
Following the issue of the new Ordinary Shares, the Company’s total issued share capital with voting rights and which is admitted to trading on AIM will consist of 55,376,006 ordinary shares of 5p each, with one voting right per share.
| Enquiries | |||
| Eco Animal Health Group plc | |||
| Peter Lawrence, Executive Chairman | 020 8336 6190 | ||
| Spiro Financial | |||
| Anthony Spiro | 020 8336 6196 | ||
| Cenkos Securities plc (Nominated adviser) | |||
| Stephen Keys | 020 7397 8926 | ||
| Elizabeth Bowman | 020 7397 8928 |
ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.
Copyright Business Wire 2013